# US 2012/0252894 A1 · Compounds for alleviating pain and stress in fetus and newborn

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252894 A1
- Document ID: US20120252894A1
- Status: Published application
- Kind: A1
- Application number: 13/435,522
- Filed: 2012-03-30
- Published: 2012-10-04
- Earliest claimed: 2011-04-01
- Inventors: Giniatullin Rashid; Khazipov Roustem; Ben-Ari Yehezkel; Mazzuca Michel; Tyzio Roman
- Web page: https://patentgrep.com/patent/US20120252894A1

## CPC

- A61K 31/195: having an amino group
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- G01N 33/5058: {Neurological cells}
- G01N 33/6872: {Intracellular protein regulatory factors and their receptors, e.g. including ion channels}
- G01N 2500/04: Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
- G01N 2800/2842: Pain, e.g. neuropathic pain, psychogenic pain
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention relates to a compound which inhibits the importation of chloride into neurons or a compound which improve the outflow of chloride from neurons thereby promoting the inhibitory actions of GABA and alleviating pain and stress of the fetus during delivery and the newborn. The invention also relates to a pharmaceutical composition for use in a method for alleviating pain and stress of the fetus during delivery and the newborn comprising a compound according to the invention and a pharmaceutically acceptable carrier.

## Claims

### Claim 1

A compound which inhibits the importation of chloride into neurons or a compound which improve the outflow of chloride from neurons formulated for use in a method for alleviating pain and stress in fetus and newborn.

### Claim 2 (depends on 1)

A compound according to the claim 1, wherein said compound inhibits the NKCC co-transporter or activates the KCC co-transporter.

### Claim 3 (depends on 1)

A compound according to the claim 1 wherein said compound is an antagonist of NKCC1.

### Claim 4 (depends on 1)

A compound according to the claim 1 wherein the compound is a diuretic.

### Claim 5 (depends on 1)

A compound according to the claim 1 wherein the compound is bumetanide.

### Claim 6 (depends on 1)

A pharmaceutical composition for use in for use in a method for alleviating pain and stress in a fetus or newborn comprising a compound according to claim 1 and a pharmaceutically acceptable carrier, said composition formulated for delivery to said fetus or newborn.

### Claim 7

A method for screening a drug for use in a method for alleviating pain and stress in a fetus or newborn comprising the steps of:
a. providing neurons expressing NKCC or KCC on their surface;
b. incubating said cells with a candidate compound;
c. determining whether said candidate compound binds to and inhibits NKCC or binds to and activates KCC; and
d. selecting the candidate compound that binds to and inhibits NKCC or binds to and activates KCC.

### Claim 8

A method for alleviating pain and stress in a fetus or newborn, comprising:
administering to a fetus or newborn subject in need thereof a compound which inhibits the importation of chloride into neurons or a compound which improves the outflow of chloride from neurons.

### Claim 9 (depends on 8)

The method of claim 8 wherein said compound inhibits the NKCC co-transporter or activates the KCC co-transporter.

### Claim 10 (depends on 8)

The method according to claim 8 wherein said compound is an antagonist of NKCC1.

### Claim 11 (depends on 8)

The method according to claim 8 wherein the compound is a diuretic.

### Claim 12 (depends on 8)

The method according to claim 8 wherein the compound is bumetanide.
